Two novel classes of bicarbocyclic dideoxynucleosides have been synthe
sized for antiviral studies. The key intermediates, 9 and 23, synthesi
zed in multiple steps from readily available monocyclic or bicyclic pr
ecursors, were coupled with the desired heterocyclic bases to afford,
after further elaboration, the corresponding bicarbocyclic dideoxynucl
eosides. The structure and stereochemistry of the tosylate intermediat
es and the target bicarbocyclic dideoxynucleosides were confirmed by e
xtensive H-1 and C-13 NMR studies including COSY, NOESY, DEFT, and sel
ective INEPT experiments. (C) 1997, Elsevier Science Ltd.